137 related articles for article (PubMed ID: 29930141)
1. Role of endogenous digitalis-like factors in the clinical manifestations of severe preeclampsia: a sytematic review.
Buckalew VM
Clin Sci (Lond); 2018 Jun; 132(12):1215-1242. PubMed ID: 29930141
[TBL] [Abstract][Full Text] [Related]
2. Increasing evidence for and regulation of a human placental endogenous digitalis-like factor.
Ma J; Esplin MS; Adair CD; Mason LA; Graves SW
Reprod Sci; 2012 Apr; 19(4):437-48. PubMed ID: 22344738
[TBL] [Abstract][Full Text] [Related]
3. Digoxin antibody fragment, antigen binding (Fab), treatment of preeclampsia in women with endogenous digitalis-like factor: a secondary analysis of the DEEP Trial.
Lam GK; Hopoate-Sitake M; Adair CD; Buckalew VM; Johnson DD; Lewis DF; Robinson CJ; Saade GR; Graves SW
Am J Obstet Gynecol; 2013 Aug; 209(2):119.e1-6. PubMed ID: 23583219
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the neutralizing activity of digoxin-specific Fab toward ouabain-like steroids.
Pullen MA; Brooks DP; Edwards RM
J Pharmacol Exp Ther; 2004 Jul; 310(1):319-25. PubMed ID: 14982968
[TBL] [Abstract][Full Text] [Related]
5. Endogenous Digitalis-like Factors as a Key Molecule in the Pathophysiology of Pregnancy-Induced Hypertension and a Potential Therapeutic Target in Preeclampsia.
Socha MW; Chmielewski J; Pietrus M; Wartęga M
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628922
[No Abstract] [Full Text] [Related]
6. Endogenous digitalis-like ligands and Na/K-ATPase inhibition in experimental diabetes mellitus.
Bagrov YY; Manusova NB; Egorova IA; Fedorova OV; Bagrov AY
Front Biosci; 2005 Sep; 10():2257-62. PubMed ID: 15970492
[TBL] [Abstract][Full Text] [Related]
7. Endogenous Na/K-ATPase inhibitors in patients with preeclampsia.
Averina IV; Tapilskaya NI; Reznik VA; Frolova EV; Fedorova OV; Lakatta EG; Bagrov AY
Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(8):19-23. PubMed ID: 17535731
[TBL] [Abstract][Full Text] [Related]
8. Interaction of Digibind with endogenous cardiotonic steroids from preeclamptic placentae.
Fedorova OV; Tapilskaya NI; Bzhelyansky AM; Frolova EV; Nikitina ER; Reznik VA; Kashkin VA; Bagrov AY
J Hypertens; 2010 Feb; 28(2):361-6. PubMed ID: 19927009
[TBL] [Abstract][Full Text] [Related]
9. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia.
Lopatin DA; Ailamazian EK; Dmitrieva RI; Shpen VM; Fedorova OV; Doris PA; Bagrov AY
J Hypertens; 1999 Aug; 17(8):1179-87. PubMed ID: 10466474
[TBL] [Abstract][Full Text] [Related]
10. Antibody to Marinobufagenin Reverses Placenta-Induced Fibrosis of Umbilical Arteries in Preeclampsia.
Fedorova OV; Ishkaraeva VV; Grigorova YN; Reznik VA; Kolodkin NI; Zazerskaya IE; Zernetkina V; Agalakova NI; Tapilskaya NI; Adair CD; Lakatta EG; Bagrov AY
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30104471
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertension.
Fedorova OV; Simbirtsev AS; Kolodkin NI; Kotov AY; Agalakova NI; Kashkin VA; Tapilskaya NI; Bzhelyansky A; Reznik VA; Frolova EV; Nikitina ER; Budny GV; Longo DL; Lakatta EG; Bagrov AY
J Hypertens; 2008 Dec; 26(12):2414-25. PubMed ID: 19008721
[TBL] [Abstract][Full Text] [Related]
12. Summary of a symposium on natriuretic and digitalis-like factors.
Buckalew VM; Gonick HC
Clin Exp Hypertens; 1998; 20(5-6):481-8. PubMed ID: 9682904
[TBL] [Abstract][Full Text] [Related]
13. Antidigoxin antibodies neutralize the effect of newborn endogenous digitalis-like factor on erythrocyte 86Rb uptake.
Balzan S; Montali U; Biver P; Ghione S
J Nucl Biol Med (1991); 1991; 35(1):38-40. PubMed ID: 1657202
[TBL] [Abstract][Full Text] [Related]
14. Different methods for measuring endogenous digitalis-like factor(s).
Paci A; Balzan S; Ledda A; Ghoine S
J Pharm Biomed Anal; 1996 Jun; 14(8-10):983-8. PubMed ID: 8818004
[TBL] [Abstract][Full Text] [Related]
15. Digoxin immune fab treatment for severe preeclampsia.
Adair CD; Buckalew VM; Graves SW; Lam GK; Johnson DD; Saade G; Lewis DF; Robinson C; Danoff TM; Chauhan N; Hopoate-Sitake M; Porter KB; Humphrey RG; Trofatter KF; Amon E; Ward S; Kennedy L; Mason L; Johnston JA
Am J Perinatol; 2010 Sep; 27(8):655-62. PubMed ID: 20232280
[TBL] [Abstract][Full Text] [Related]
16. PP087. Deep trial secondary analysis: Digoxin immune fab fragment treatment has additional benefits in endogenous digitalis-like factor positive preeclamptic women.
Graves SW; Hopoate-Sitake M; Johnston A; Buckalew V; Lam G; Mason L; Adair D
Pregnancy Hypertens; 2012 Jul; 2(3):287-8. PubMed ID: 26105409
[TBL] [Abstract][Full Text] [Related]
17. Digibind reverses inhibition of cellular rb+ uptake caused by endogenous sodium pump inhibitors present in serum and placenta of women with preeclampsia.
Hopoate-Sitake ML; Adair CD; Mason LA; Torres C; Kipikasa J; Graves SW
Reprod Sci; 2011 Feb; 18(2):190-9. PubMed ID: 20959646
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of endogenous digitalis-like factor‑induced vascular endothelial cell damage in patients with severe preeclampsia.
Peng M; Yang M; Ding Y; Yu L; Deng Y; Lai W; Hu Y
Int J Mol Med; 2018 Feb; 41(2):985-994. PubMed ID: 29251320
[TBL] [Abstract][Full Text] [Related]
19. Circulating endogenous digitalis-like factor(s) (EDLF) in man is derived from the adrenals and its secretion is ACTH-dependent.
Sophocleous A; Elmatzoglou I; Souvatzoglou A
J Endocrinol Invest; 2003 Jul; 26(7):668-74. PubMed ID: 14594120
[TBL] [Abstract][Full Text] [Related]
20. The hemodynamic effects of intravenous digoxin-binding fab immunoglobulin in severe preeclampsia: a double-blind, randomized, clinical trial.
Adair CD; Luper A; Rose JC; Russell G; Veille JC; Buckalew VM
J Perinatol; 2009 Apr; 29(4):284-9. PubMed ID: 19148110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
